Hybio Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	2015 - 2019
Cash & Equivalents	139.18	94.87	344.01	106.26	138.92	451.65	Upgrade
Trading Asset Securities	1.25	1.11	-	160.57	477.68	-	Upgrade
Cash & Short-Term Investments	140.42	95.97	344.01	266.83	616.6	451.65	Upgrade
Cash Growth	1.93%	-72.10%	28.92%	-56.73%	36.52%	-44.97%	Upgrade
Accounts Receivable	94.53	99.87	145.42	318.07	282.64	332.01	Upgrade
Other Receivables	7.01	11.15	22.44	11.88	54.39	24.08	Upgrade
Receivables	101.54	111.02	167.87	329.95	337.03	356.09	Upgrade
Inventory	288.16	238.63	152.59	189.96	157.14	186.76	Upgrade
Prepaid Expenses	-	10.29	2.56	0.19	-	-	Upgrade
Other Current Assets	34.97	7.14	16.61	25.39	44.31	52.53	Upgrade
Total Current Assets	565.09	463.05	683.64	812.32	1,155	1,047	Upgrade
Property, Plant & Equipment	1,710	1,674	1,734	1,942	1,993	1,980	Upgrade
Long-Term Investments	6.41	89.11	105.85	131.11	139.74	301.88	Upgrade
Goodwill	-	-	-	-	0.19	-	Upgrade
Other Intangible Assets	273.42	293.41	222.5	265.05	263.56	317.36	Upgrade
Long-Term Deferred Tax Assets	43.72	43.76	39.55	38.01	34.07	37.73	Upgrade
Long-Term Deferred Charges	169.39	175.99	217.81	250.41	228.02	282.37	Upgrade
Other Long-Term Assets	402.12	268.53	273.73	172.5	93.2	53.59	Upgrade
Total Assets	3,171	3,008	3,277	3,611	3,906	4,020	Upgrade
Accounts Payable	236.46	218.26	108.5	129.05	90.73	125.48	Upgrade
Accrued Expenses	13.64	78.5	100.92	49.16	72.78	36.31	Upgrade
Short-Term Debt	766.41	638.99	634.21	320.92	338.23	583.16	Upgrade
Current Portion of Long-Term Debt	290.37	293.53	453.18	456.11	63.05	218.66	Upgrade
Current Portion of Leases	-	0.82	0.21	2.88	11.06	-	Upgrade
Current Income Taxes Payable	9.51	6.72	2.84	-	0.32	2.01	Upgrade
Current Unearned Revenue	85.67	130.55	55.33	62.69	48.79	74.21	Upgrade
Other Current Liabilities	114.62	57.17	68.26	127.14	118.86	57.18	Upgrade
Total Current Liabilities	1,517	1,425	1,423	1,148	743.82	1,097	Upgrade
Long-Term Debt	869.57	864.58	942.05	1,026	1,377	1,148	Upgrade
Long-Term Unearned Revenue	96.9	106.91	101.19	118.62	124.73	90.55	Upgrade
Long-Term Deferred Tax Liabilities	11.63	8.84	5.01	4.2	0.81	1.1	Upgrade
Other Long-Term Liabilities	9.79	6.29	22.29	17.06	12.3	6.26	Upgrade
Total Liabilities	2,505	2,411	2,494	2,314	2,258	2,342	Upgrade
Common Stock	883.24	883.24	883.24	916.93	916.93	916.93	Upgrade
Additional Paid-In Capital	1,448	1,448	1,463	1,748	1,700	1,777	Upgrade
Retained Earnings	-1,722	-1,794	-1,627	-1,113	-740	-770.81	Upgrade
Treasury Stock	-	-	-	-318.66	-318.66	-318.66	Upgrade
Comprehensive Income & Other	40.38	41.22	39.27	37.5	26.51	33.02	Upgrade
Total Common Equity	649.15	578.63	758.8	1,271	1,585	1,638	Upgrade
Minority Interest	16.93	18.42	24.41	26.3	63.31	40.34	Upgrade
Shareholders' Equity	666.08	597.05	783.21	1,297	1,648	1,678	Upgrade
Total Liabilities & Equity	3,171	3,008	3,277	3,611	3,906	4,020	Upgrade
Total Debt	1,926	1,798	2,030	1,806	1,789	1,949	Upgrade
Net Cash (Debt)	-1,786	-1,702	-1,686	-1,540	-1,173	-1,498	Upgrade
Net Cash Per Share	-2.02	-1.96	-1.90	-1.74	-1.14	-1.62	Upgrade
Filing Date Shares Outstanding	857.32	883.24	883.24	883.24	883.24	883.24	Upgrade
Total Common Shares Outstanding	857.32	883.24	883.24	883.24	883.24	883.24	Upgrade
Working Capital	-951.59	-961.51	-739.8	-335.63	411.26	-49.98	Upgrade
Book Value Per Share	0.76	0.66	0.86	1.44	1.79	1.85	Upgrade
Tangible Book Value	375.73	285.21	536.31	1,006	1,321	1,320	Upgrade
Tangible Book Value Per Share	0.44	0.32	0.61	1.14	1.50	1.49	Upgrade
Buildings	-	1,577	1,560	1,537	1,058	609.4	Upgrade
Machinery	-	896.3	832.92	774.95	769.85	648.13	Upgrade
Construction In Progress	-	37.11	67.32	153.99	699.74	1,188	Upgrade

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.